We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.14B
AUM Growth
+$154M
Cap. Flow
-$40.8M
Cap. Flow %
-0.99%
Top 10 Hldgs %
16.44%
Holding
571
New
34
Increased
180
Reduced
255
Closed
24

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$28M
2
EFX icon
Equifax
EFX
+$18.7M
3
AAPL icon
Apple
AAPL
+$16.9M
4
PH icon
Parker-Hannifin
PH
+$14.4M
5
ARES icon
Ares Management
ARES
+$7.03M

Sector Composition

Rank Sector Weight
1 Healthcare 17.26%
2 Industrials 15.16%
3 Financials 14.07%
4 Technology 13.51%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQC
176
DELISTED
Equity Commonwealth
EQC
$4.86M 0.12%
155,667
-6,958
-4% -$216K
LUMO
177
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$4.86M 0.12%
22,392
-245
-1% -$35K
WSBC icon
178
WesBanco
WSBC
$3.95B
$4.84M 0.12%
127,092
+105,627
+492% +$4.27M
NJR icon
179
New Jersey Resources
NJR
$6.06B
$4.84M 0.12%
122,219
+15,253
+14% +$576K
BANR icon
180
Banner Corp
BANR
$2.39B
$4.83M 0.12%
86,753
-3,956
-4% -$226K
OMCL icon
181
Omnicell
OMCL
$1.86B
$4.82M 0.12%
118,522
+23,345
+25% +$860K
GVA icon
182
Granite Construction
GVA
$5.45B
$4.78M 0.12%
+95,200
New +$5.07M
EMN icon
183
Eastman Chemical
EMN
$7.8B
$4.77M 0.12%
59,016
-1,050
-2% -$82.6K
CERN
184
DELISTED
Cerner Corp
CERN
$4.76M 0.12%
80,937
-62,828
-44% -$3.4M
BRK.A icon
185
Berkshire Hathaway Class A
BRK.A
$1.07T
$4.75M 0.11%
19
MCO icon
186
Moody's
MCO
$81.7B
$4.67M 0.11%
41,664
+1,000
+2% +$107K
BWLD
187
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$4.66M 0.11%
30,505
-2,356
-7% -$360K
MDRX
188
DELISTED
Veradigm Inc. Common Stock
MDRX
$4.65M 0.11%
366,821
-55,794
-13% -$662K
COLM icon
189
Columbia Sportswear
COLM
$3.19B
$4.58M 0.11%
78,041
+4,836
+7% +$271K
AIT icon
190
Applied Industrial Technologies
AIT
$12.8B
$4.57M 0.11%
73,938
+17,915
+32% +$1.11M
CIM
191
Chimera Investment
CIM
$1.05B
$4.5M 0.11%
74,352
-3,865
-5% -$215K
NEE icon
192
NextEra Energy
NEE
$187B
$4.49M 0.11%
139,908
-760
-0.5% -$23.9K
MKTX icon
193
MarketAxess Holdings
MKTX
$4.15B
$4.47M 0.11%
23,866
-1,209
-5% -$219K
MNDT
194
DELISTED
Mandiant, Inc. Common Stock
MNDT
$4.46M 0.11%
+354,009
New +$4.22M
MRVL icon
195
Marvell Technology
MRVL
$174B
$4.42M 0.11%
289,824
-72,710
-20% -$1.12M
ENR icon
196
Energizer
ENR
$1.44B
$4.42M 0.11%
79,206
+1,888
+2% +$99.5K
A icon
197
Agilent Technologies
A
$39.1B
$4.39M 0.11%
83,091
-4,210
-5% -$213K
RRX icon
198
Regal Rexnord
RRX
$14.2B
$4.39M 0.11%
58,019
-3,117
-5% -$230K
NX icon
199
Quanex
NX
$854M
$4.36M 0.11%
+215,313
New +$4.28M
VIAV icon
200
Viavi Solutions
VIAV
$9.75B
$4.31M 0.1%
401,898
-304,439
-43% -$2.96M

Similar funds

Segall Bryant & Hamill's Q1 2017 Portfolio in Review

As of Q1 2017, Segall Bryant & Hamill held 571 positions worth $4.14B, up 3.9% from $3.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Segall Bryant & Hamill's Q1 2017 filing shows 34 new, 180 increased, 255 reduced and 24 closed positions. Its largest new stake was Parker-Hannifin: 94,689 shares worth $15.2M. The largest sale was Gildan, an estimated $26M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q1 2017 buy was Parker-Hannifin: 94,689 shares worth $15.2M.
  • Segall Bryant & Hamill added most to Zoetis in Q1 2017, an estimated $28M increase.
  • Segall Bryant & Hamill's biggest Q1 2017 reduction was Gildan, cutting an estimated $26M.
  • Segall Bryant & Hamill fully exited Mentor Graphics Corp in Q1 2017, selling an estimated $10.6M.
  • Segall Bryant & Hamill's ten largest holdings make up 16% of its $4.14B portfolio in Q1 2017.
  • Segall Bryant & Hamill opened 34 new positions and closed 24 in Q1 2017.
  • Segall Bryant & Hamill's portfolio value rose 3.9% quarter-over-quarter to $4.14B.

Based on Segall Bryant & Hamill's 13F filing for Q1 2017, filed 12 May 2017.